Criteria for the definition of the eosinophilia-myalgia syndrome

Journal of Rheumatology

Volumn 23, Issue SUPPL. 46, 1996, Pages 7-12

  Hertzman, Phillip A ^a  

^a Los Alamos Oversight Bureau   (United States)

Author keywords

diagnosis; eosinophilia myalgia syndrome; epidemiology; L tryptophan

Indexed keywords

TRYPTOPHAN;

CONFERENCE PAPER; DISEASE CLASSIFICATION; EOSINOPHILIA MYALGIA SYNDROME; HISTOPATHOLOGY; HUMAN; PRIORITY JOURNAL; ACUTE DISEASE; PATHOPHYSIOLOGY; PUBLIC HEALTH SERVICE; REVIEW; UNITED STATES;

ACUTE DISEASE; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); EOSINOPHILIA-MYALGIA SYNDROME; HUMANS; UNITED STATES;

EID: 0029802489     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (36)

1. Eosinophilia-myalgia syndrome - New Mexico. MMWR Morb Mortal Wkly Rep 1989;38:765-7.
2. Hertzman PA, Blevins WL, Mayer J, Greenfield B, Ting M, Gleich GJ: Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan. N Engl J Med 1990;322:869-73.
3. Varga J, Heinman-Patterson TD, Emery DL, et al: Clinical spectrum of the systemic manifestations of the eosinophilia-myalgia syndrome. Semin Arthritis Rheum 1990;19:313-28.
4. Swygert LA, Maes EF, Sewell LE, Miller L, Falk H, Kilbourne EM: Eosinophilia myalgia syndrome: Results of national surveillance. JAMA 1990;264:1698-703.
5. Belongia EA, Hedberg CW, Gleich GJ, et al: An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use. N Engl J Med 1990;323:357-63.
6. Henning KJ, Jean-Baptiste E, Singh T, Hill RH, Friedman SM: Eosinophilia-myalgia syndrome in patients ingesting a single source of L-tryptophan. J Rheumatol 1993;20:273-8.
7. Kamb ML, Murphy JJ, Jones JL, et al: Eosinophilia-myalgia syndrome in L-tryptophan exposed patients. JAMA 1992;267:77-82.
8. Slutzger L, Hoesly FC, Miller L, et al: Eosinophilia-myalgia syndrome associated with exposure to tryptophan from a single manufacturer. JAMA 1990;264:213-7.
9. Duffy J: The lessons of the eosinophilia-myalgia syndrome. Hosp Pract 1992;27:65-90.
10. Eidson M, Philen RM, Sewell CM, Voorhees R, Kilbourne EM: L-tryptophan and eosinophilia-myalgia syndrome in New Mexico. Lancet 1990;335:645-8.
11. Brigden ML, Horak MG: Incidence and clinical significance of unsuspected eosinophilia discovered by automated WBC differential counting. Lab Med 1993;24:173-6.
12. Spry CJ: Eosinophilia. Practitioner 1982;26:79-88.
13. Clinical spectrum of eosinophilia-myalgia syndrome - California. MMWR Morb Mortal Wkly Rep 1990;39:89-91.
14. Back EE: Eosinophilia-myalgia syndrome. NYSDOH Epidemiology Notes 1990;5.
15. Philen R, Eidson M, Kilbourne E, Sewell CM, Voorhees R: Eosinophilia-myalgia syndrome: A clinical case series of 21 patients. New Mexico Eosinophilia-Myalgia Syndrome Study Group. Arch Intern Med 1991;151:533-7.
16. Hertzman P, Graham K: The eosinophilia-myalgia syndrome - follow-up (abstr). Arthritis Rheum 1991;(suppl)34:S131.
17. Hertzman PA, Clauw D, Kaufman L, et al: 18-24 month structured follow-up of 210 patients with eosinophilia-myalgia syndrome (EMS) in 12 states (abstr). Arthritis Rheum 1993;(suppl)36:R26.
18. Kaufman L, Gruber BL, Gregerson PK: Clinical follow-up and immunogenetic studies of 32 patients with eosinophilia-myalgia syndrome. Lancet 1991;337:1071-4.
19. Feldman SR, Silver RM, Malize JC: A histopathologic comparison of Shulman's s syndrome (diffuse fasciitis with eosinophilia) and the fasciitis associated with the eosinophilia-myalgia syndrome. J Am Acad Dermatol 1992;26:95-100.
20. Kaufman LD, Seidman RJ, Phillips ME, Gruber BL: Cutaneous manifestations of the L-tryptophan-associated eosinophilia-myalgia syndrome: A spectrum of sclerodermatous skin disease. J Am Acad Dermatol 1990;23:1063-9.
21. Marting RW, Duffy J, Engel AG, et al: The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion: Clinical features in twenty patients and aspects of pathophysiology. Ann Intern Med 1990;113:124-34.
22. Heiman-Patterson TD, Bird SJ, Parry GJ, et al: Peripheral neuropathy of the eosinophilia-myalgia syndrome. J Neuropathol Exp Neurol 1991;28:522-8.
23. Seidman RJ, Kaufman LD, Sokoloff L, et al: The neuromuscular pathology of the eosinophilia-myalgia syndrome. J Neuropathol Exp Neurol 1991;50:49-62.
24. Smith BE, Dyck PJ: Peripheral neuropathy in the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Neurology 1990;40:1035-40.
25. Tazelaar HD, Myers JL, Drage CW, et al: Pulmonary disease associated with L-tryptophan-induced eosinophilia-myalgia syndrome. Chest 1990;97:1032-6.
26. Strumpf IJ, Drucker RD, Anders KH, et al: Acute eosinophilic pulmonary disease associated with the ingestion of L-tryptophan-containing products. Chest 1991;99:8-13.
27. Hertzman PA, Falk H, Kilbourne EM, Page S, Shulman LE: The eosinophilia-myalgia syndrome: The Los Alamos Conference. J Rheumatol 1991;18:867-73.
28. Duffy J, Engel AF, Bowles C: Eosinophilia-myalgia syndrome (EMS) not associated with L-tryptophan (LT) (abstr). Arthritis Rheum 1991;(suppl)34:S132.
29. Hibbs JR, Mittleman B, Hill P, Medsger TA: L-tryptophan-associated eosinophilic fasciitis prior to the 1989 eosinophilia-myalgia syndrome outbreak. Arthritis Rheum 1992;35:299-303.
30. Waller PA, Clauw D, Cupps T, Metcalf JS, Silver RM, Leroy EC: Fasciitis (not scleroderma) following prolonged exposure to an organic solvent, trichloroethylene. J Rheumatol 1994;21:1567-70.
31. Clauw DJ, Mullins KW, Blank C: Eosinophilia-myalgia syndrome (EMS) is not associated with ingestion of nutritional supplements (abstr). Arthritis Rheum 1993;(suppl)36:R26.
32. Spitzer WO, Haggerty J, Berkson L, et al: Continuing occurrence of eosinophilia-myalgia syndrome in Canada. Br J Rheumatol 1995;34:246-51.
33. Bochner BS, Friedman B, Krishnaswami G, et al: Episodic eosinophilia-myalgia-like syndrome in a patient without L-tryptophan use: Association with eosinophil activation and increased levels of granulocyte-manophage colony-stimulating factor. J Allergy Clin Immunol 1992;88:629-36.
34. Feinstem AR: Clinical biostatistics: XLVI. What are the criteria for criteria? Clin Pharm Ther 1970;25:108-16.
35. Bloch DA, Moses LE, Michel BA: Statistical approaches to classification. Arthritis Rheum 1990;33:1137-44.
36. McNeil BJ, Keeler E, Adelstein SJ: Primer on certain elements of medical decision making. N Engl J Med 1975;293:211-5.